Клиническая медицина betamimetics, where the gravity of the pathology
requires. Such situations are encountered in ad-
vanced stages of COPD with high level of bron-
chial obstruction. In these situations, patients
with serious symptoms, carry out the investiga-
tions, substance inhaled bronchodilators improv-
ing bronchial obstruction degree. After previous
exposure and as a finally conclusion, results and
discussions are eloquent for the purpose of the
present study.
REFERENCES 1 Airflow limitation by the Global Lungs
Initiative equations in a cohort of very old adults /
E. Turkeshi, B. Vaes, E. Andreeva et al. //Eur.
Respir. J. –
2015.
–
V. 46. –
Pp. 123-132.
2 Association between emphysema-like
lung on cardiac computed tomography and mor-
tality in persons without airflow obstruction: a
cohort study /E. C. Oelsner, E. A. Hoffman, A. R.
Folsom et al. //Ann. Intern. Med. –
2014.
–
V.
161.
–
Pp. 863-873.
3 Clinical relevance of diagnosing COPD by
fixed ratio or lower limit of normal: a systematic
review /W. D. van Dijk, N. Gupta, W. C. Tan et
al. //COPD. –
2014.
–
V. 11. –
Pp. 113-120.
4 COPD prevalence in a random population
survey: a matter of definition /P. Shirtcliffe, M.
Weatherall, S. Marsh et al. //Eur. Respir. J. –
2007.
–
V. 30. –
Pp. 232-239.
5 Crapo R. O. Reference spirometric values
using techniques and equipment that meet ATS
recommendations /R. O. Crapo, A. H. Morris, R.
M. Gardner //Am. Rev. Respir. Dis. –
1981.
–
V.
123.
–
Pp. 659-664.
6 Dynamic laryngeal narrowing during
exercise: a mechanism for generating intrinsic
PEEP in COPD? /M.
Baz
, G. S.
Haji
,
A. Menzies-
Gow et al. //Thorax. –
2015.
–
V. 70. –
Pp. 251-
257.
7 Fletcher C. The natural history of chronic
airflow obstruction /C. Fletcher, R. Peto //Br.
Med. J. –
1977.
–
V. 1. –
Pp. 1645-1648.
8 Global strategy for the diagnosis, man-
agement, and prevention of chronic obstructive
pulmonary disease: NHLBI/WHO 13. Global Initia-
tive for Chronic Obstructive Lung Disease (GOLD)
Workshop summary /R. A. Pauwels, A. S. Buist,
P. M. A. Calverley et al. //Am. J. Respir. Crist.
Care. Med. –
2001.
–
V. 163. –
Pp. 1256-1276.
9 Global strategy for the diagnosis, man-
agement, and prevention of chronic obstructive
pulmonary disease: GOLD executive summary /K.
F. Rabe, S. Hurd, A. Anzueto et al. //Am. J.
Respir. Crist. Care. Med. –
2007.
–
V. 176. –
Pp.
532-555.
10 Hegerl U. Depression and suicidality in
COPD: understandable reaction or independent
disorders? /U. Hegerl, R. Mergl //Eur. Respir. J. –
2014.
–
V. 44. –
Pp. 734-743.
11 Interpretative strategies for lung
function tests /R. Pellegrino, G. Veii, V. Brusasco
et al. //Eur. Respir. J. –
2005.
–
V. 26. –
Pp. 948-
968.
12 Jones W Paul. Depression: a character-
istic comorbidity of COPD? //Eur. Respir. J. –
2014.
–
V. 44. –
Pp. 570-571.
13 Mannino D. M. Interpreting lung func-
tion data using 80% predicted and fixed thresh-
olds identifies patients at increased risk of mortal-
ity /D. M. Mannino, E. Diaz-Guzman //Chest. –
2012 .
–
V. 141. –
Pp. 73-80.
14 Mannino D. M. Obstructive pulmonary
disease in the older adult: what defines abnormal
lung function? /D. M. Mannino, A. S. Buist, W. M.
Vollmer //Thorax. –
2007.
–
V. 62. –
Pp. 237-241.
15 Population impact of different defini-
tions of airway obstruction /B. R. Celli, R. J. Hal-
bert, S. Isonaka et al. //Eur. Respir. J. –
2003.
–
V. 22. –
Pp. 268-273.
16 Reference ranges for spirometry across
all ages: a new approach /S. Stanojevic, A. Wade,
J. Stocks et al. //Am. J. Respir. Crist. Care. Med.
–
2008.
–
V. 177. –
Pp. 253-260.
17 Smoking cessation strategies in patients
with COPD /J. M. Warnier, E. S. E. van Riet, H.
Frans et al. //Eur. Respir. J. –
2013.
–
V. 41. –
Pp. 727-734.
18 Standards for the diagnosis and treat-
ment of patients with COPD: a summary of the
ATS/ERS position paper /B. R. Celli, W. MacNee,
A. Agusti et al. //Eur. Respir. J. –
2004.
–
V. 23. –
Pp. 932-946.
19 Swanney M. P. Adopting universal lung
function reference equations /M. P. Swanney, M.
Miller //Eur. Respir. J. –
2013.
–
V. 42. –
Pp. 901-
903.
20 The ratio of FEV
1
to FVC as a basis for
establishing chronic obstructive pulmonary dis-
ease /C. A. Vaz Fragoso, J. Concato, G. McAvay
et al. //Am. J. Respir. Crist. Care. Med. –
2010.
–
V. 181. –
Pp. 446-451.
21 The relations between structural chang-
es in small airways and pulmonary-function
tests /M. Casio, H. Ghezzo, J. C. Hogg et al. //N.
Engl. J. Med. –
1978.
–
V. 298. –
Pp. 1277-1281.
22 Using the lower limit of normal for the
FEV
1
/FVC ratio reduces the misclassification of
airway obstruction /M. P. Swanney, G. Ruppel, P.
L. Enright et al. //Thorax. –
2008.
–
V. 63. –
Pp.
1046-1051.
Received 01.09.21